mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.5 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.5 |